Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Launch of US version of Beating the Blues

6th Oct 2011 12:00

RNS Number : 6843P
Ultrasis PLC
06 October 2011
 



6 October 2011

 

 

Ultrasis plc

("Ultrasis" or the "Company")

 

Launch of US version of Beating the Blues

 

 

Ultrasis, the leading provider of cognitive behavioural therapy for stress and mild depression delivered by computer, is pleased to announce the formal launch of U Squared Interactive LLC ("U²"), its 50:50-owned joint-venture with UPMC Insurance Services, which will be used to launch the US-specific version of "Beating the Blues" ("BtB US") to the American market.

 

In addition, Ultrasis is pleased to announce the completion of the development BtB US which will be marketed in the US via U², and for which U² is currently in ongoing discussions with a number of interested parties.

 

For further details, please visit: www.U2interactive.com and www.beatingthebluesus.com.

 

As previously announced on 27 February 2011, both Ultrasis and UPMC will invest to develop and drive sales opportunities across US states, government bodies, insurers, primary care providers, major corporations and other health care providers, who seek to enhance their mental health and well-being services.

 

 

 

 

-ENDS-

 

For further information contact:

 

Ultrasis plc

Nigel Brabbins, CEO

 

Tel: +44 (0) 20 7535 2050 

Strand Hanson Limited

Stuart Faulkner / Liam Buswell

 

Tel: +44 (0) 20 7409 3494

JBP Public Relations

Tel: +44 (0) 11 7907 3414

Chris Lawrance

 

 

Editors Notes:

About Ultrasis

 

Ultrasis is a healthcare company with core expertise in health, psychology, software development and programme management. The Company delivers computerised healthcare products to the NHS, the corporate sector and other healthcare providers in the UK and internationally.

 

Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy ("CBT") and interactive multimedia and is the world leader in this field. The products help people tackle stress, anxiety and depression, and a full spectrum of related chronic conditions.

 

Beating the Blues is an eight-week, web-based treatment programme for mild and moderate depression based on CBT.

 

Following a rigorous examination by the National Institute for Health and Clinical Excellence ("NICE"), Beating the Blues was approved by NICE in February 2006 for use in the National Health Service.

 

For more information on Ultrasis please visit www.ultrasis.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFSMSUMFFSESS

Related Shares:

Ultrasis Plc
FTSE 100 Latest
Value8,275.66
Change0.00